RLAY — Relay Therapeutics Share News
0.000.00%
Last trade - 00:00- $3.19bn
- $2.55bn
- $15.36m
Relay Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Brief: Relay Therapeutics Reports First Quarter 2023 Financial Results And Corporate Highlights
Relay Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Relay Therapeutics Inc expected to post a loss of 69 cents a share - Earnings Preview
Relay Therapeutics gains as Raymond James upgrades shares to 'strong buy'
U.S. RESEARCH ROUNDUP-First Solar, Lockheed Martin, MSCI
Relay Therapeutics falls as efficacy data for cancer drug disappoints
Brief: Relay Therapeutics Announces Initial Clinical Data Demonstrating That Rly-2608 Selectively Targets Multiple Pi3kα Mutations
Relay Therapeutics gains after Raymond James initiates with 'outperform'
Biotech stocks down on SVB fallout concerns but analysts see limited impact for now
Brief: Relay Therapeutics To Present Initial Clinical Data On Rly-2608 At AACR
Brief: Relay Therapeutics Reports Fourth Quarter And Full Year 2022 Financial Results And Corporate Highlights
Relay Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Relay Therapeutics Inc expected to post a loss of 70 cents a share - Earnings Preview
Relay Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Relay Therapeutics Inc expected to post a loss of 71 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Akouos, Core & Main, Revance Therapeutics
U.S. STOCKS ON THE MOVE-Planet Labs, Catalyst Pharma, Akero
Relay Therapeutics slips after pricing $300 mln stock offering